Japan Neuromodulation Devices Market Outlook to 2033 - Implantable Neuromodulation Devices and Non-Invasive Neuromodulation Devices

The Japan Neuromodulation Devices Market report provides key information and data on:

Annualized market revenues (USD), volume (units) and average prices (USD) data for each of the market segments. Data is provided from 2018 to 2033.
2025 company share data for Neuromodulation Devices Market.
Global corporate-level profiles of key companies operating within the Japan Neuromodulation Devices Market. Based on the availability of data for the particular category and country, information related to pipeline products, news and deals is also available in the report.

Report Scope

Japan Neuromodulation Devices is segmented as follows:

Implantable Neuromodulation Devices
Minimally Invasive Neuromodulation Devices
Non-Invasive Neuromodulation Devices

Reasons to Buy

The Japan Neuromodulation Devices Market report helps you to develop:

Business strategies by identifying the key market segments poised for strong growth in the future.
Market-entry and market expansion strategies.
Design competition strategies by identifying who-stands-where in the market.
Develop investment strategies by identifying the key market segments expected to register strong growth in the near future.

1 Table of Contents

1.1 List of Tables
1.2 List of Figures

2 Introduction

2.1 What Is This Report About?
2.2 Neuromodulation Devices Market Segmentation
2.3 Definitions of Markets Covered in the Report

3 Neuromodulation Devices Market, Japan

3.1 Neuromodulation Devices Market, Japan, Revenue ($m), 2018-2033
3.1.1 Implantable Neuromodulation Devices Market, Japan, Revenue ($m), by Segment, 2018-2033
3.2 Neuromodulation Devices Market, Japan, Volume (Units), 2018-2033
3.2.1 Implantable Neuromodulation Devices Market, Japan, Volume (Units), by Segment, 2018-2033
3.3 Neuromodulation Devices Market, Japan, Average Price ($), 2018-2033
3.4 Neuromodulation Devices Market, Japan, Company Share by Revenue ($m), 2025

4 Overview of Key Companies in Japan, Neuromodulation Devices Market

4.1 Medtronic Plc
4.1.1 Company Overview
4.2 Boston Scientific Corp
4.2.1 Company Overview
4.3 LivaNova Plc
4.3.1 Company Overview
4.4 Abbott Laboratories
4.4.1 Company Overview
4.5 Enterra Medical Inc
4.5.1 Company Overview
4.6 B. Braun Melsungen AG
4.6.1 Company Overview

5 Neuromodulation Devices Market Pipeline Products

6 Recent Developments

6.1 Corporate Communications
6.1.1 Oct 06, 2025: GSK Appoints Luke Miels As CEO Designate
6.1.2 Sep 09, 2025: Pioneering Sustainability: Teijin Carbon Publishes Its First Sustainability Report
6.2 Financial Announcements
6.2.1 Aug 05, 2025: Teijin Reports Results for Three Months Ended June 30, 2025
6.3 Product News
6.3.1 Sep 29, 2025: Development of a Wireless Multifunctional Brain Oxygen Monitor for Rehabilitation and Daily Use
6.3.2 Mar 03, 2025: KYOCERA to Showcase Ceramic Lab Analytic Technologies for Multilayer Direct Bonding, Ceramic Additive Manufacturing, and Sapphire Apertures at Pittcon 2025
6.4 Research And Development
6.4.1 Sep 29, 2025: Development of a Wireless Multifunctional Brain Oxygen Monitor for Rehabilitation and Daily Use

7 Appendix

7.1 Research Methodology
7.1.1 Coverage
7.1.2 Secondary Research
7.1.3 Primary Research
7.1.4 Market Modeling and Forecasting
7.1.5 Company Share Analysis
7.1.6 Benchmarking
7.2 the analyst Consulting
7.3 Contact the Publisher
7.4 Disclaimer

List of Tables

Table 1: Neuromodulation Devices Market, Japan, Revenue ($m), USD Constant, 2018-2033
Table 2: Implantable Neuromodulation Devices Market, Japan, Revenue ($m), USD Constant, 2018-2033
Table 3: Neuromodulation Devices Market, Japan, Volume (Units), 2018-2033
Table 4: Implantable Neuromodulation Devices Market, Japan, Volume (Units), 2018-2033
Table 5: Neuromodulation Devices Market, Japan, Average Price ($), 2018-2033
Table 6: Neuromodulation Devices Market, Japan, Company Share by Revenue ($m), 2025
Table 7: Neuromodulation Devices Market Pipeline Products
Table 8: Total Number of Primary Research Participants, Neurology Devices Market, by Country

List of Figures

Figure 1: Neuromodulation Devices Market, Japan, Revenue ($m), USD Constant, 2018-2033
Figure 2: Implantable Neuromodulation Devices Market, Japan, Revenue ($m), USD Constant, 2018-2033
Figure 3: Neuromodulation Devices Market, Japan, Volume (Units), 2018-2033
Figure 4: Implantable Neuromodulation Devices Market, Japan, Volume (Units), 2018-2033
Figure 5: Neuromodulation Devices Market, Japan, Company Share (%), 2025

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

Medtronic Plc
Boston Scientific Corp
LivaNova Plc
Abbott Laboratories
Enterra Medical Inc
B. Braun Melsungen AG

License	Format	Properties	Price
SINGLE USER LICENSE PDF	The product is a PDF.	This is a single user license, allowing one user access to the product.	€4480EUR$4,995USD£3,875GBP
SITE LICENSE PDF	The product is a PDF.	This is a site license, allowing all users within a given geographical location of your organization access to the product.	€8959EUR$9,990USD£7,750GBP
ENTERPRISE LICENSE PDF	The product is a PDF.	This is an enterprise license, allowing all employees within your organization access to the product.	€13439EUR$14,985USD£11,626GBP

The Japan Neuromodulation Devices Market report provides key information and data on:

Report Scope

Japan Neuromodulation Devices is segmented as follows:

Reasons to Buy

The Japan Neuromodulation Devices Market report helps you to develop:

Table of Contents

Companies Mentioned (Partial List)

Related Topics

Related Reports

Asia-Pacific Neuromodulation Devices Market Outlook to 2033 - Deep Brain Stimulators (DBS), Spinal Cord Stimulators (SCS), Vagus Nerve Stimulators (VNS) and Others

Neuromodulation Devices Market Size by Segments, Share, Regulatory, Reimbursement, Interventions and Forecast to 2036

Neuromodulation Devices Market Size, Share & Trends Analysis Report by Product (Spinal Cord Stimulators, Deep Brain Stimulators, Sacral Nerve Stimulators), Application (Migraine, Epilepsy, Chronic Pain, Depression), End-use, and Region with Growth Forecasts, 2026-2033

Neuromodulation Market Report by Technology, Biomaterial, Application, and Region 2025-2033

Internal Neuromodulation Devices Market Report 2026